基于脂复合技术的埃斯库林输送系统:研究可溶性优化和抗菌活性改善
Jiale Mao1, Lixin Yi2,3, Honghui Zhao1
1Faculty of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, China.
Natural product research
|June 20, 2025
概括
这项研究开发了一种埃斯林脂复合物 (ES-PC) 来改善埃斯林.
科学领域:
- 食品科学与技术 食品科学与技术
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
背景情况:
- 埃斯库林 (ES) 具有抗菌性质,但溶解性和生物可用性差,阻碍了其实际应用.
- 开发有效的输送系统对于提高像埃斯库林这样的溶性较差的化合物的效用至关重要.
研究的目的:
- 准备和表征一种埃斯库林脂复合物 (ES-PC),以提高埃斯库林的溶解性和生物可用性.
- 评估ES-PC在复合膜中用于保存猪肉的有效性.
- 探索一种用于不溶性化合物的新型药物输送系统.
主要方法:
- 使用溶剂蒸发方法合成了埃斯库林脂复合物 (ES-PC).
- 描述涉及扫描电子显微镜 (SEM),富里埃变换红外光谱 (FTIR),X射线衍射 (XRD) 和1H核磁共振 (1H-NMR).
- 评估了可溶性,水友性 (八醇-水分区系数) 和溶解率. 在猪肉保存复合膜中测试了有效性.
主要成果:
- ES-PC表现出一种无形结构,由分子间力量稳定.
- 与ES相比,ES-PC显示水溶性增加了13.8倍,n-octanol溶性增加了7.3倍.
- 在4小时内,ES-PC显示累积溶解率超过85%,有效抑制细菌生长,保持低pH和TVB-N值,延长猪肉的保质期.
结论:
- 开发出来的埃斯林脂复合物 (ES-PC) 显著增强了埃斯林的可溶性,溶解性和生物可用性.
- 纳入复合膜的ES-PC通过抑制细菌生长和保持质量参数,有效地保护猪肉.
- 这项研究提出了一个可行的策略,用于开发可溶性较低的药物先进的输送系统,扩大其应用范围.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
671
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
671
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
329
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
329
Bioavailability Enhancement: Drug Solubility Enhancement
446
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
446
Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
310
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
310
Production of Pharmaceuticals
65
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
65


